Study on 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identifying and Treating PSMA-Expressing Metastatic Castrate Resistant Prostate Cancer | Clinical Trial

Study on 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identifying and Treating PSMA-Expressing Metastatic Castrate Resistant Prostate Cancer | Clinical Trial | Right2Hope